German generics trade association Pro Generika has called for a draft bill from the country’s federal ministry for health, Bundesministerium für Gesundheit, to go further in addressing the impact of supply chain bottlenecks on the German market. The current draft only addresses antibiotic and oncology medicines, which Pro Generika says make up just 1.1% of all daily therapy doses.
Bork Bretthauer, managing director of Pro Generika, said: “Politicians have recognized that prioritizing cheap generics has destabilized supply and is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?